Related Articles for PubMed (Select 18489783)

Nathan RA, Bernstein JA, Bielory L, Bonuccelli CM, Calhoun WJ, Galant SP, Hanby LA, Kemp JP, Kylstra JW, Nayak AS, O'Connor JP, Schwartz HJ, Southern DL, Spector SL, Williams PV.

J Allergy Clin Immunol. 1998 Dec;102(6 Pt 1):935-42.

PMID: 9847434 [PubMed - indexed for MEDLINE]

Exhaled nitric oxide continues to reflect airway hyperresponsiveness and disease activity in inhaled corticosteroid-treated adult asthmatic patients.

Reid DW, Johns DP, Feltis B, Ward C, Walters EH.

Respirology. 2003 Dec;8(4):479-86.

PMID: 14629652 [PubMed - indexed for MEDLINE]

10:

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.

Virchow JC Jr, Prasse A, Naya I, Summerton L, Harris A.

Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):578-85.

PMID: 10934090 [PubMed - indexed for MEDLINE]

11:

Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

Suissa S, Dennis R, Ernst P, Sheehy O, Wood-Dauphinee S.

Ann Intern Med. 1997 Feb 1;126(3):177-83.

PMID: 9027267 [PubMed - indexed for MEDLINE]

12:

Zafirlukast improves pulmonary function in patients with moderate persistent asthma receiving regular inhaled steroids: a prospective randomized control study.

Huang CJ, Wang CH, Liu WT, Yang MC, Lin HC, Yu CT, Shiao CJ, Tan CC, Yang CK, Kuo HP.

Chang Gung Med J. 2003 Aug;26(8):554-60.

PMID: 14609035 [PubMed - indexed for MEDLINE]

13:

Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.

Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Taylor DR.

Respir Med. 2000 Aug;94(8):767-71.

PMID: 10955752 [PubMed - indexed for MEDLINE]

14:

An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses.

Tashkin DP, Nathan RA, Howland WC, Minkwitz MC, Simonson SG, Bonuccelli CM.

J Allergy Clin Immunol. 1999 Feb;103(2 Pt 1):246-54.

PMID: 9949315 [PubMed - indexed for MEDLINE]

15:

Effectiveness and tolerability of zafirlukast for the treatment of asthma in children.

Pearlman DS, Lampl KL, Dowling PJ Jr, Miller CJ, Bonuccelli CM.

Clin Ther. 2000 Jun;22(6):732-47.

PMID: 10929920 [PubMed - indexed for MEDLINE]

16:

Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.

Norris V, Choong L, Tran D, Corden Z, Boyce M, Arshad H, Holgate S, O'Connor B, Millet S, Miller B, Rohatagi S, Kirkesseli S.

J Allergy Clin Immunol. 2005 Oct;116(4):761-7. Epub 2005 Aug 19.

PMID: 16210048 [PubMed - indexed for MEDLINE]

17:

Daily versus as-needed corticosteroids for mild persistent asthma.

Boushey HA, Sorkness CA, King TS, Sullivan SD, Fahy JV, Lazarus SC, Chinchilli VM, Craig TJ, Dimango EA, Deykin A, Fagan JK, Fish JE, Ford JG, Kraft M, Lemanske RF Jr, Leone FT, Martin RJ, Mauger EA, Pesola GR, Peters SP, Rollings NJ, Szefler SJ, Wechsler ME, Israel E; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network.

N Engl J Med. 2005 Apr 14;352(15):1519-28.

PMID: 15829533 [PubMed - indexed for MEDLINE]

18:

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.

Fish JE, Kemp JP, Lockey RF, Glass M, Hanby LA, Bonuccelli CM.

Clin Ther. 1997 Jul-Aug;19(4):675-90.

PMID: 9377612 [PubMed - indexed for MEDLINE]

19:

Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials.

Barnes NC, Miller CJ.

Thorax. 2000 Jun;55(6):478-83.

PMID: 10817796 [PubMed - indexed for MEDLINE]

Recent Activity